SuperworthREGENXBIO shares outstanding RGNX
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 53M
- On a year earlier
- +3.0%
- more shares
REGENXBIO had 53M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 51.8M | +2% |
| FY2024 | 50.9M | +16% |
| FY2023 | 44M | +2% |
| FY2022 | 43.3M | −2% |
| FY2021 | 44.3M | +18% |
| FY2020 | 37.4M | +1% |
| FY2019 | 36.9M | −5% |
| FY2018 | 38.9M | +25% |
| FY2017 | 31.2M | +18% |
| FY2016 | 26.5M | +1% |
| FY2015 | 26.3M | +896% |
| FY2014 | 2.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 53M | +3% | |
| Q1 FY26 | 52.4M | +2% | |
| Q4 FY25 | 51.8M | +2% | |
| Q3 FY25 | 51.7M | +2% | |
| Q2 FY25 | 51.5M | +2% | |
| Q1 FY25 | 51.4M | +12% | |
| Q4 FY24 | 50.9M | +16% | |
| Q3 FY24 | 50.8M | +16% | |
| Q2 FY24 | 50.6M | +16% | |
| Q1 FY24 | 45.7M | +5% | |
| Q4 FY23 | 44M | +2% | |
| Q3 FY23 | 43.9M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on REGENXBIO
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.